Prostaglandin conjugates for treating or preventing bone disease
US6121253A · kind A · utility
27Cited by
12References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 1999 |
| Grant date | Sep 19, 2000 |
| Priority date | — |
| Expiry date | Nov 15, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/3865
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to prostaglandin-bisphosphonate conjugates. These conjugates are effective for treating or preventing bone diseases such as osteoporosis. These conjugates simultaneously deliver a prostaglandin agent for increasing bone formation and a bisphosphonate agent for inhibiting bone resorption.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.